Copyright
©The Author(s) 2023.
World J Transplant. Sep 18, 2023; 13(5): 208-220
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.208
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.208
| Current indications for SPK in T1DM |
| Confirmed diabetic nephropathy with low or absent C-peptide, on insulin treatment |
| Creatinine clearance < 15 mL/min or on dialysis |
| Presence of other microvascular or macrovascular complications of T1DM |
| Ability to withstand immunosuppression and surgery |
| History of compliance with medical advice and treatment |
| Absolute contraindications for SPK in T1DM |
| Significant cardiovascular disease with severe or non-correctable coronary artery disease |
| Cardiac ejection fraction < 50% |
| Recent myocardial infarction |
| Non-curable malignancy except localized skin cancer |
| Active sepsis |
| Active peptic ulcer disease |
| Severe mental health conditions that can lead to non-compliance |
| Inability to survive surgery or immunosuppression due to significant comorbidity |
| Relative contraindications for SPK in T1DM |
| Cerebrovascular event with long-standing impairment |
| Human immunodeficiency virus, hepatitis B and C virus infections |
| BMI > 30 kg/m2 |
| Age > 60 yrs |
| Extensive vascular, aortic, and renal artery disease (making surgery high-risk) |
| Excessive need for insulin > 1.5 U/kg/d |
| Continuous use of alcohol, smoking, and other drugs |
- Citation: Nagendra L, Fernandez CJ, Pappachan JM. Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: Current perspectives. World J Transplant 2023; 13(5): 208-220
- URL: https://www.wjgnet.com/2220-3230/full/v13/i5/208.htm
- DOI: https://dx.doi.org/10.5500/wjt.v13.i5.208
